Hanmi Science Co (XKRX:008930) Debt-to-Equity : 0.27 (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Hanmi Science Co Debt-to-Equity?

Hanmi Science Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩202,967 Mil. Hanmi Science Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩10,769 Mil. Hanmi Science Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩787,507 Mil. Hanmi Science Co's debt to equity for the quarter that ended in Dec. 2023 was 0.27.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Hanmi Science Co's Debt-to-Equity or its related term are showing as below:

XKRX:008930' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.07 Max: 0.28
Current: 0.27

During the past 13 years, the highest Debt-to-Equity Ratio of Hanmi Science Co was 0.28. The lowest was 0.03. And the median was 0.07.

XKRX:008930's Debt-to-Equity is ranked better than
51.81% of 83 companies
in the Medical Distribution industry
Industry Median: 0.29 vs XKRX:008930: 0.27

Hanmi Science Co Debt-to-Equity Historical Data

The historical data trend for Hanmi Science Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Science Co Debt-to-Equity Chart

Hanmi Science Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.07

0.08

0.28

0.27

Hanmi Science Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.28	0.26	0.25	0.24	0.27

Competitive Comparison of Hanmi Science Co's Debt-to-Equity

For the Medical Distribution subindustry, Hanmi Science Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hanmi Science Co's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Hanmi Science Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Hanmi Science Co's Debt-to-Equity falls into.

Hanmi Science Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Hanmi Science Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(202967.456	+	10768.617)	/	787506.951
	=	0.27

Hanmi Science Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(202967.456	+	10768.617)	/	787506.951
	=	0.27

Hanmi Science Co (XKRX:008930) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Hanmi Science Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Hanmi Science Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hanmi Science Co (XKRX:008930) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hanmi Science Co Ltd (XKRX:008930) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

214 Muha-ro Paltan-myeon, Gyeonggi-do, Hwaseong, KOR

Website

http://www.hanmi.co.kr

Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.

Hanmi Science Co (XKRX:008930) Headlines

No Headlines